Fragmin (dalteparin sodium) is used to prevent blood clots forming in blood vessels. It is used in different conditions such as deep vein thrombosis, unstable . dalteparin sodium 10 anti-Xa units/mL injection, 10 x 1 mL syringes (PI, CMI), 2, 20, 3 dalteparin sodium 12 anti-Xa units/ mL injection, 10 x mL. To collect postmarketing data about Fragmin safety and efficacy in the treatment of deep vein thrombosis with or without pulmonary embolism in cancer patients.
|Published (Last):||10 April 2014|
|PDF File Size:||3.95 Mb|
|ePub File Size:||14.71 Mb|
|Price:||Free* [*Free Regsitration Required]|
The most commonly reported adverse reactions are hematoma at the injection site and hemorrhagic complications. Let go of the plunger and fgagmin syringe to move up inside the device until the entire needle is guarded. Of the total number of patients in clinical studies of Fragmin, patients were 65 years of age or older and were 75 or older.
Of the patients enrolled, were treated and underwent surgery. When given at a dose of 5, IU once a day subcutaneously, Fragmin significantly reduced the incidence of thromboembolic reactions including verified DVT by Day 21 see Table In patients with chronic renal insufficiency requiring hemodialysis, the mean terminal half-life of anti-Factor Xa activity following a single intravenous dose of 5, IU Fragmin was 5.
The combined incidence of death, MI, need for intravenous heparin or intravenous. When monitoring anti-Xa in these patients, perform sampling 4—6 hrs after Fragmin dosing and only after the patient has received 3—4 doses.
Table 9 summarizes the number of patients with bleeding reactions that occurred in the clinical trial of patients with cancer and acute symptomatic venous thromboembolism. The “gasping syndrome” is characterized by central nervous system depression, metabolic acidosis, and gasping respirations.
In some cases the hematoma resulted in long-term or permanent paralysis partial or complete [ see Boxed Warning ]. The mean age of the study population was 64 years range 25 to 92 years and the majority of patients were white Epidural or spinal hematomas may occur in patients who are anticoagulated with low molecular weight heparins LMWH or heparinoids and are receiving neuraxial anesthesia or undergoing spinal puncture.
Approval History FDA approved In a double-blind, multi-center, randomized, placebo-controlled clinical trial, general medical patients with severely restricted mobility who were at risk of venous thromboembolism were randomized to receive either Fragmin 5, IU or placebo subcutaneously once daily during Days 1 to 14 of the study.
The molecular weight distribution is:. Treatment should be continued until the patient is clinically stabilized. Medically reviewed on Sep 1, The following serious adverse reactions are described in more detail in other sections of the prescribing information.
Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or fragmn a causal relationship to fdagmin exposure.
Primary Endpoints – 6 day timepoint Death, MI. Because fatal reactions, often resembling anaphylaxis, have been reported with protamine sulfate, give protamine sulfate only when resuscitation techniques and treatment for anaphylactic shock are readily available. In clinical practice, cases of thrombocytopenia with thrombosis, amputation and death have been observed [ see Contraindications 4 ].
Inspect Fragmin prefilled syringes and vials visually for particulate matter and discoloration prior to administration. Hold the syringe assembly by the open sides of the device. Treatment was continued for 6 to 8 days. Dalteparin is a low molecular weight heparin with antithrombotic properties.
Factors that can increase the risk of developing epidural or spinal hematomas in these patients include: These patients had an acute medical condition requiring a projected hospital stay of at least 4 days, and were confined to bed during waking hours.
Anti-Factor Xa may be cragmin to monitor the anticoagulant effect of Fragmin, such as in patients with severe renal impairment or if abnormal coagulation parameters or bleeding occurs during Fragmin therapy.
The samples were collected before and 3—4 hours after daily injections of IU ffragmin. Some studies suggest that the risk of bleeding increases with age. It was not mutagenic in the in vitro Ames Test, mouse lymphoma cell forward mutation test and human lymphocyte chromosomal aberration test and in the in vivo mouse micronucleus test.
Fragmin – FDA prescribing information, side effects and uses
Fragmin is also indicated for the prophylaxis of deep vein thrombosis DVTwhich may lead to pulmonary embolism PE:. The mean age of the study population was cragmin years range 18 to 91 years and the majority of patients were white In an open-label randomized study, Fragmin 5, IU administered once daily subcutaneously was compared with warfarin sodium, administered orally, in patients undergoing hip replacement surgery.
At the end of the six-month study, a total of 46 Of the 1, patients enrolled, 1, patients were treated; received Fragmin and received heparin. A third multi-center, double-blind, randomized study evaluated a postoperative dosing regimen of Fragmin for thromboprophylaxis following total hip replacement surgery.
When the area around the navel or the thigh is used, using the thumb and forefinger, you must lift frxgmin a fold of skin while giving fgagmin injection.